Allyson J. Ocean, Professor of Clinical Medicine at Weill Cornell Medicine, shared a post by Agenus, adding:
“It’s amazing to see tumors disappear without chemotherapy or surgery… hoping that this treatment will be available to more patients in the future.”
“Real innovation in cancer care cannot be incremental — especially for patients facing tumors that have historically resisted immunotherapy.
Over the past year, Agenus has continued to generate compelling clinical data for hashtag#BOT + BAL, while seeing growing interest from physicians and patients around the world. In parallel, we are strengthening manufacturing capabilities and infrastructure to support expanding clinical and access programs.
The science is advancing. The evidence is growing.
And the foundation is being built to bring these therapies to more patients.
Sharing perspective from Garo Armen following our 2025 earnings update.”